/DaVita%20Inc%20sign%20on%20building-by%20photo-denver%20via%20Shutterstock.jpg)
Based in Denver, Colorado, DaVita Inc. (DVA) is a global leader in providing kidney care services. It is renowned for its comprehensive range of treatments and services to improve the quality of life for patients with chronic kidney disease and end-stage renal disease. With a market cap of $11.93 billion, DaVita is recognized for its innovative care models, patient-centered approach, and commitment to clinical excellence. DVA is scheduled to announce its fiscal Q2 earnings results on Thursday, Aug. 1.
Ahead of the event, analysts expect DVA to report a profit of $2.47 per share, up 18.8% from $2.08 per share in the year-ago quarter. The company has consistently surpassed Wall Street’s EPS estimates in its last four quarterly reports.